VIPoma historical perspective: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}} | {{CMG}}{{AE}}{{MSI}}{{PSD}} | ||
==Overview== | ==Overview== | ||
VIPoma also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison. | VIPoma also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 14:42, 19 January 2018
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma historical perspective On the Web |
|
American Roentgen Ray Society Images of VIPoma historical perspective |
|
Risk calculators and risk factors for VIPoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
VIPoma also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison.
Historical Perspective
The neuroendocrine tumours of the gastrointestinal tract and pancreas were discovered after Rudolf Heidenhain first found out the neuroendocrine cells in 1870. VIPoma was first described in 1958 by American physicians, John U. Verner (endocrinologist) and Ashton B. Morrison (pathologist) in two patients with profuse diarrhea and hypokalemia due to malignancy of non-insulin producing pancreatic islets. VIPoma is also known as Verner-Morrison syndrome named after its discovering physicians.[1]
References
- ↑ Belei OA, Heredea ER, Boeriu E, Marcovici TM, Cerbu S, Mărginean O; et al. (2017). "Verner-Morrison syndrome. Literature review". Rom J Morphol Embryol. 58 (2): 371–376. PMID 28730220.